Preventing substitution errors involving high-concentration heparin products.
Critical care practitioners routinely administer heparin for various indications (e.g., treatment of acute coronary syndrome, venous thromboembolism prophylaxis, line maintenance) and by various routes (e.g., intravenously, subcutaneously). Knowledge of reported incidents involving high-concentration heparin products can increase practitioner awareness of risks for error-induced injury associated with storage and administration of anticoagulants, such as heparin. Substitution errors leading to administration of an incorrect dose of unfractionated heparin are highlighted and suggestions for system-based error prevention strategies are provided.
Koczmara
Christine
C
Institute for Safe Medication Practices Canada.
Cheng
Roger
R
Hyland
Sylvia
S
D016907:Adverse Drug Reaction Reporting Systems; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D002170:Canada; D002626:Chemistry, Pharmaceutical; D003422:Critical Care / Q000458:organization & administration*; D004348:Drug Labeling; D006301:Health Services Needs and Demand; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008508:Medication Errors / Q000379:methods / Q000451:nursing / Q000517:prevention & control* / Q000706:statistics & numerical data; D009730:Nursing Assessment; D012308:Risk Management / Q000458:organization & administration*; D013597:Systems Analysis
D000925:Anticoagulants; D006493:Heparin